Paclitaxel inhibits arterial smooth muscle cell proliferation and migration in vitro and in vivo using local drug delivery.

BACKGROUND The antineoplastic compound paclitaxel (Taxol) causes an increased assembly of extraordinarily stable microtubules. The present study was designed to characterize the effects of paclitaxel on proliferation and migration of human arterial smooth muscle cells (haSMCs) in vitro and on neointima formation in an in vivo experimental rabbit model. METHODS AND RESULTS Both monocultures of haSMCs and cocultures with human arterial endothelial cells (haECs) were used. Cell growth after 4, 8, and 14 days was determined in the absence or presence of platelet-derived growth factor-AB (PDGF-AB), basic fibroblast growth factor (bFGF), or thrombin. Nonstop paclitaxel exposure, as well as single-dose applications of paclitaxel for 24 hours or even 20 minutes (0.1 to 10.0 micromol/L), caused a complete and prolonged inhibition of haSMC growth up to day 14, with an IC50 of 2.0 nmol/L. Mitogens or cocultures with stimulating haECs did not significantly attenuate paclitaxel-induced effects. Immunohistochemistry showed characteristic cytoskeletal changes predominantly in the microtubule network. Additionally, in 20 male New Zealand White rabbits, intimal plaques were produced by electrical stimulation. In 10 animals, paclitaxel was locally applied by use of microporous balloons. Histologically, the intima wall area, wall thickness, and degree of stenosis were reduced significantly in paclitaxel-treated animals compared with controls. CONCLUSIONS Our data show that paclitaxel inhibits haSMC proliferation and migration in a dose-dependent manner in monocultures and cocultures even in the presence of mitogens. Furthermore, paclitaxel prevents neointima formation in rabbits after balloon angioplasty. The long-lasting effect after just several minutes' exposure time makes this lipophilic substance a promising candidate for local antiproliferative therapy of restenosis.

[1]  M. Karin,et al.  Cytoskeletal control of gene expression: depolymerization of microtubules activates NF-kappa B , 1995, The Journal of cell biology.

[2]  M. De Brabander,et al.  Microtubule dynamics during the cell cycle: the effects of taxol and nocodazole on the microtubule system of Pt K2 cells at different stages of the mitotic cycle. , 1986, International review of cytology.

[3]  G. Majno,et al.  Apoptosis, oncosis, and necrosis. An overview of cell death. , 1995, The American journal of pathology.

[4]  G. Demers,et al.  Loss of normal p53 function confers sensitization to Taxol by increasing G2/M arrest and apoptosis , 1996, Nature Medicine.

[5]  K. Karsch,et al.  Induction of cell-rich and lipid-rich plaques in a transfilter coculture system with human vascular cells. , 1996, Journal of vascular research.

[6]  G. Stouffer,et al.  TGF-beta promotes proliferation of cultured SMC via both PDGF-AA-dependent and PDGF-AA-independent mechanisms. , 1994, The Journal of clinical investigation.

[7]  D. Roth,et al.  In vitro model of the inner parts of a vessel wall with cultured human vascular cells , 1993, Coronary artery disease.

[8]  P. Schiff,et al.  Promotion of microtubule assembly in vitro by taxol , 1979, Nature.

[9]  D. Albertini,et al.  The effects of taxol on the organization of the cytoskeleton in cultured ovarian granulosa cells. , 1983, European journal of cell biology.

[10]  M. Jordan,et al.  Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[11]  C. Fairchild,et al.  Paclitaxel inhibits progression of mitotic cells to G1 phase by interference with spindle formation without affecting other microtubule functions during anaphase and telephase. , 1994, Cancer research.

[12]  N K Hollenberg,et al.  Persistent dysfunction of regenerated endothelium after balloon angioplasty of rabbit iliac artery. , 1990, Circulation.

[13]  G. Edelman,et al.  Density-dependent stimulation and inhibition of cell growth by agents that disrupt microtubules. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[14]  L. M. May,et al.  Distribution of microtubule organizing centers in migrating sheets of endothelial cells , 1981, The Journal of cell biology.

[15]  P. Kiener,et al.  Activation of p34cdc2 coincident with taxol-induced apoptosis. , 1994, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[16]  P. Schiff,et al.  Taxol stabilizes microtubules in mouse fibroblast cells. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[17]  N. Saijo,et al.  Enhanced interaction between tubulin and microtubule‐associated protein 2 via inhibition of MAP kinase and CDC2 kinase by paclitaxel , 1995, International journal of cancer.

[18]  E J Topol,et al.  The restenosis paradigm revisited: an alternative proposal for cellular mechanisms. , 1992, Journal of the American College of Cardiology.

[19]  W. B. Derry,et al.  Substoichiometric binding of taxol suppresses microtubule dynamics. , 1995, Biochemistry.

[20]  K. Gelmon.  The taxoids: paclitaxel and docetaxel , 1994, The Lancet.

[21]  J. Isner,et al.  Prospects for site-specific delivery of pharmacologic and molecular therapies. , 1994, Journal of the American College of Cardiology.

[22]  K. Karsch,et al.  Vascular Injury and Time Course of Smooth Muscle Cell Proliferation After Experimental Holmium Laser Angioplasty , 1992, Circulation.

[23]  A. Gotlieb,et al.  In vitro endothelial wound repair. Interaction of cell migration and proliferation. , 1990, Arteriosclerosis.

[24]  G M Edelman,et al.  Surface modulation in cell recognition and cell growth. , 1976, Science.

[25]  F. Denizot,et al.  Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. , 1986, Journal of immunological methods.

[26]  I. Gelfand,et al.  Role of the microtubular system in morphological organization of normal and oncogene-transfected epithelial cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[27]  H. Fessi,et al.  In vitro and in vivo antitumoral activity of free, and encapsulated taxol. , 1990, Journal of microencapsulation.

[28]  K. Crossin,et al.  Evidence that microtubule depolymerization early in the cell cycle is sufficient to initiate DNA synthesis , 1981, Cell.

[29]  R. Straubinger,et al.  Novel Taxol formulations: Taxol-containing liposomes. , 1993, Journal of the National Cancer Institute. Monographs.

[30]  C. Lambert,et al.  Local drug delivery catheters: functional comparison of porous and microporous designs , 1993, Coronary artery disease.

[31]  K. L. Donaldson,et al.  Cytotoxicity of the anticancer agents cisplatin and taxol during cell proliferation and the cell cycle , 1994, International journal of cancer.

[32]  D. Hathaway,et al.  Biodegradable microspheres containing a colchicine analogue inhibit DNA synthesis in vascular smooth muscle cells. , 1994, Circulation.

[33]  B A Danowski,et al.  Fibroblast contractility and actin organization are stimulated by microtubule inhibitors. , 1989, Journal of cell science.

[34]  C. Nathan,et al.  Taxol shares the ability of bacterial lipopolysaccharide to induce tyrosine phosphorylation of microtubule-associated protein kinase. , 1993, Journal of Immunology.

[35]  C. Manthey,et al.  Taxol increases steady-state levels of lipopolysaccharide-inducible genes and protein-tyrosine phosphorylation in murine macrophages. , 1992, Journal of immunology.

[36]  K. Karsch,et al.  Inhibition of Cellular Proliferation After Experimental Balloon Angioplasty by Low‐Molecular‐Weight Heparin , 1992, Circulation.

[37]  E. Lakatta,et al.  Taxol inhibits neointimal smooth muscle cell accumulation after angioplasty in the rat. , 1995, The Journal of clinical investigation.

[38]  J. Fleiss,et al.  Some Statistical Methods Useful in Circulation Research , 1980, Circulation research.

[39]  K. Crossin,et al.  Microtubule stabilization by taxol inhibits initiation of DNA synthesis by thrombin and by epidermal growth factor , 1981, Cell.

[40]  K. Karsch,et al.  Time course of smooth muscle cell proliferation in the intima and media of arteries following experimental angioplasty. , 1990, Circulation research.

[41]  H. Gratzner,et al.  Monoclonal antibody to 5-bromo- and 5-iododeoxyuridine: A new reagent for detection of DNA replication. , 1982, Science.

[42]  E. Rozengurt,et al.  Enhancement of DNA synthesis by colchicine in 3T3 mouse fibroblasts stimulated with growth factors. , 1980, Experimental cell research.

[43]  P. Nielsen,et al.  Photofootprinting of drug-binding sites on DNA using diazo- and azido-9-aminoacridine derivatives. , 1989, European journal of biochemistry.

[44]  M. Furusawa,et al.  Difference in cytotoxicity of paclitaxel against neoplastic and normal cells. , 1994, Anticancer research.

[45]  R. Weiss,et al.  The mitogenic effect of thrombin in vascular smooth muscle cells is largely due to basic fibroblast growth factor. , 1993, The Journal of biological chemistry.

[46]  C. Manthey,et al.  Lipopolysaccharide antagonists block taxol-induced signaling in murine macrophages , 1993, The Journal of experimental medicine.

[47]  K. Bhalla,et al.  Taxol induces internucleosomal DNA fragmentation associated with programmed cell death in human myeloid leukemia cells. , 1993, Leukemia.

[48]  Z. Darżynkiewicz,et al.  Detection of DNA strand breaks in individual apoptotic cells by the in situ terminal deoxynucleotidyl transferase and nick translation assays. , 1993, Cancer research.

[49]  A. Bajer,et al.  Action of taxol on mitosis: modification of microtubule arrangements and function of the mitotic spindle in Haemanthus endosperm , 1983, The Journal of cell biology.

[50]  H. Hämmerle,et al.  Human endothelial cells are stimulated and vascular smooth muscle cells are inhibited in their proliferation and migration by heparins. , 1991, VASA. Zeitschrift fur Gefasskrankheiten.

[51]  A. Otto,et al.  Microtubule-disrupting agents affect two different events regulating the initiation of DNA synthesis in Swiss 3T3 cells. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[52]  N. Fineberg,et al.  Local delivery of biodegradable microparticles containing colchicine or a colchicine analogue: effects on restenosis and implications for catheter-based drug delivery. , 1995, Journal of the American College of Cardiology.

[53]  R. Donehower,et al.  Drug therapy : paclitaxel (Taxol) , 1995 .